Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006827
Filing Date
2017-04-21
Accepted
2017-04-21 13:45:03
Documents
5
Period of Report
2017-06-09
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A albo-def14a_20170609.htm DEF 14A 1203056
2 GRAPHIC g201704211614311447700.jpg GRAPHIC 58973
3 GRAPHIC g201704211614221857698.jpg GRAPHIC 4765
4 GRAPHIC g201704211614311727701.jpg GRAPHIC 72081
5 GRAPHIC g201704211614225407699.jpg GRAPHIC 3484
  Complete submission text file 0001564590-17-006827.txt   1396682
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33451 | Film No.: 17775167
SIC: 2834 Pharmaceutical Preparations